Journal of Medical Economics
Volume 25, 2022 - Issue 1
Open access
4,399
Views
7
CrossRef citations to date
0
Altmetric
Hepatology
Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease
Vinod K. Rustgia Department of Medicine, Division of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA;b Center for Liver Diseases and Masses, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USACorrespondence[email protected]
https://orcid.org/0000-0002-4105-5783
Steve B. Duffc Veritas Health Economics Consulting, Inc, Carlsbad, CA, USA
https://orcid.org/0000-0002-0506-2900
Mohamed I. Elsaida Department of Medicine, Division of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA;d Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH, USA
https://orcid.org/0000-0001-7963-2438
Pages 347-355
|
Received 21 Sep 2021, Accepted 05 Jan 2022, Published online: 11 Mar 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.